BioSpace News Archive

Company Further Strengthens IP Portfolio with New USPTO Notice of Allowance

Pan-Cancer MSI Companion Diagnostic for KEYTRUDA® (pembrolizumab) Planned for Inclusion on FoundationOne CDx™

Lupin Confirms Validity of OMIDRIA Patents

Company’s abrasion tip support catheter demonstrated safe and effective

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, announced today that, as expected, the Company received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1)

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company.

Despite increasing costs to payers, the average patient with commercial insurance paid less than $500 per year for outpatient non-retail medicines in 2017 For retail medicines, patients often use coupons to reduce out-of-pocket cost at pharmacies

For the first time, BioPharmX will share its research at the Congress of Clinical Dermatology

Pivotal bioVenture Partners China (Pivotal China), a member of Nan Fung Life Sciences (NLFS) announced today the closing of Pivotal bioVenture Partners China USD Fund I, raising $150 million to incubate and build Life Sciences companies in China.

LabConnect, LLC has completed phase one of an 11,000+ square foot facility expansion in Johnson City, Tennessee.